Paion Ag (Paion Ag) Cash-to-Debt : 0.22 (As of Jun. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Paion Ag Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Paion Ag's cash to debt ratio for the quarter that ended in Jun. 2023 was 0.22.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Paion Ag couldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2023.

The historical rank and industry rank for Paion Ag's Cash-to-Debt or its related term are showing as below:

PAIOF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.22 Med: No Debt Max: No Debt
Current: 0.22

During the past 13 years, Paion Ag's highest Cash to Debt Ratio was No Debt. The lowest was 0.22. And the median was No Debt.

PAIOF's Cash-to-Debt is ranked worse than
74.69% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs PAIOF: 0.22

Paion Ag Cash-to-Debt Historical Data

The historical data trend for Paion Ag's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Paion Ag Cash-to-Debt Chart

Paion Ag Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

No Debt

4.24

771.77

0.32

0.52

Paion Ag Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Cash-to-Debt	Get a 7-Day Free Trial															0.93	0.32	0.87	0.52	0.22

Competitive Comparison of Paion Ag's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paion Ag's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Paion Ag's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Paion Ag's Cash-to-Debt falls into.

Paion Ag Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Paion Ag's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	11.26	/	(1.517	+	20.042)
	=	0.52

Paion Ag's Cash to Debt Ratio for the quarter that ended in Jun. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	5.035	/	(3.004	+	20.018)
	=	0.22

Paion Ag (OTCPK:PAIOF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Paion Ag Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Paion Ag's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Paion Ag (Paion Ag) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Paion Ag (OTCPK:PAIOF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

PA8:Germany

Address

Heussstrasse 25, Aachen, DEU, 52078

Website

https://www.paion.com

Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.

Paion Ag (Paion Ag) Headlines

From GuruFocus

PAION AG: Mundipharma Receives Market Approval for Anerem(R) (Remimazolam) In General Anesthesia in Japan

By [email protected] [email protected] • 01-23-2020